Aplastic Anemia in China

Aplastic anemia (AA) is a hematologic disease characterized by pancytopenia. Up to now, severe aplastic anemia (SAA) has been recognized by international and domestic scholars as an autoimmune disease with bone marrow (BM) failure mediated by the hyperfunctional T lymphocytes. The incidence of AA is...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chunyan, Shao, Zonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231301/
https://www.ncbi.nlm.nih.gov/pubmed/30425949
http://dx.doi.org/10.2478/jtim-2018-0028
_version_ 1783370194259804160
author Liu, Chunyan
Shao, Zonghong
author_facet Liu, Chunyan
Shao, Zonghong
author_sort Liu, Chunyan
collection PubMed
description Aplastic anemia (AA) is a hematologic disease characterized by pancytopenia. Up to now, severe aplastic anemia (SAA) has been recognized by international and domestic scholars as an autoimmune disease with bone marrow (BM) failure mediated by the hyperfunctional T lymphocytes. The incidence of AA is more in China compared with other countries. In the recent years, both the pathogenesis and treatment of AA have made a great progress in our country. Thus, the therapeutic effect of AA was much better than before. Here, we conclude the researches of AA in China.
format Online
Article
Text
id pubmed-6231301
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-62313012018-11-13 Aplastic Anemia in China Liu, Chunyan Shao, Zonghong J Transl Int Med Review Article Aplastic anemia (AA) is a hematologic disease characterized by pancytopenia. Up to now, severe aplastic anemia (SAA) has been recognized by international and domestic scholars as an autoimmune disease with bone marrow (BM) failure mediated by the hyperfunctional T lymphocytes. The incidence of AA is more in China compared with other countries. In the recent years, both the pathogenesis and treatment of AA have made a great progress in our country. Thus, the therapeutic effect of AA was much better than before. Here, we conclude the researches of AA in China. Sciendo 2018-10-09 /pmc/articles/PMC6231301/ /pubmed/30425949 http://dx.doi.org/10.2478/jtim-2018-0028 Text en © 2018 Chunyan Liu, Zonghong Shao, published by Sciendo http://creativecommons.org/licenses/by-nc-nd/3.0 This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
spellingShingle Review Article
Liu, Chunyan
Shao, Zonghong
Aplastic Anemia in China
title Aplastic Anemia in China
title_full Aplastic Anemia in China
title_fullStr Aplastic Anemia in China
title_full_unstemmed Aplastic Anemia in China
title_short Aplastic Anemia in China
title_sort aplastic anemia in china
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231301/
https://www.ncbi.nlm.nih.gov/pubmed/30425949
http://dx.doi.org/10.2478/jtim-2018-0028
work_keys_str_mv AT liuchunyan aplasticanemiainchina
AT shaozonghong aplasticanemiainchina

Ejemplares similares